

Psychedelics Without Hallucinations: A New Mental Health Treatment? with David E. Olson
Jan 11, 2024
David E. Olson, founding director of the UC Davis Institute of Psychedelics and Neurotherapeutics, discusses the potential of developing non-hallucinogenic psychedelics for mental health treatment. The podcast explores the therapeutic effects of psychedelics on neuropsychiatric diseases and the need for rapid and effective treatments. The development of novel compounds called cycloplastogens, which promote neuronal growth, is also discussed along with the accessibility of psychedelic therapies and clinical trials.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Developing Novel Compounds for Therapeutic Effects
01:53 • 10min
Revolutionary Psychedelics and Manifestation of Mental Disorders
11:45 • 2min
Understanding Neuronal Communication and Repairing Damaged Neural Circuits
13:52 • 2min
The Development of Non-Hallucinogenic Cycloplastogens for Mental Health Treatment
15:56 • 14min
Exploring Therapy Options and Clinical Trials for Psychedelic Treatments
29:33 • 2min